nav emailalert searchbtn searchbox tablepage yinyongbenwen piczone journalimg journalInfo journalinfonormal searchdiv searchzone qikanlogo popupnotification paper paperNew
2023, 05, v.42;No.427 514-517
赵恒侠从阴虚夹瘀论治甲状腺相关眼病合并胫前黏液性水肿
基金项目(Foundation): 广东省基础与应用基础研究基金项目(编号:2019A1515110108);; 陕西中医药大学张学文国医大师中医传承内分泌工作团队项目(编号:SZSM201512043);; 李惠林广东省名老中医药专家传承工作室项目(粤中医办函[2022]52号)
邮箱(Email):
DOI: 10.16295/j.cnki.0257-358x.2023.05.017
移动端阅读
摘要:

总结赵恒侠教授从阴虚夹瘀论治甲状腺相关眼病合并胫前黏液性水肿的临床经验。赵教授认为此病以心肝肾阴虚为本、瘀浊内阻为标,治疗中应辨清本虚标实,从阴虚夹瘀的病机特点出发,辨三阴之虚,以安“君主”、辅“将军”、助“作强”,养血活血以利水消肿,再以整体观念辨“余贼”,减少疾病的复发从而促进其痊愈。附验案1则。

Abstract:

This article summarizes Professor ZHAO Hengxia's clinical experience in treating thyroid-related eye disease complicated with anterior tibial mucinous edema from yin deficiency and blood stasis. Professor ZHAO holds that this disease is mainly based on the deficiency of yin of the heart,liver and kidney,which is complicated with blood stasis and internal obstruction. Therefore,distinguishing deficiency in origin and excess in superficiality should be given priority to the treatment,and starting from the pathogenesis of yin deficiency and blood stasis,deficiency of yin of the heart,liver and kidney should be distinguished to soothe“the monarch”,assist “the general” and help “the kidney”,nourishing and promoting blood circulation to remove stasis and relieve edema,then,the holistic concept is applied to distinguish the remaining pathogenic factors,reduce the recurrence of the disease so as to promote its recovery. One successful case is attached.

参考文献

[1] GENERE N,STAN M N. Current and emerging treatment strategies for Graves’ orbitopathy[J]. Drugs,2019,79(2):109-124.

[2]齐书静.胫前粘液性水肿的临床诊治[J].双足与保健,2018,27(8):96,98.

[3] FATOURECHI V. Thyroid dermopathy and acropachy[J].Best Pract Res Clin Endocrinol Metab,2012,26(4):553-565.

[4]顾鸣宇,彭永德.甲状腺相关眼病药物治疗[J].中国实用内科杂志,2015,35(7):569-571.

[5]谭芳,余叶蓉.胫前粘液性水肿的临床诊治[J].实用医院临床杂志,2014,11(1):26-28.

[6]张学文.瘀血证治[M].西安:陕西科学技术出版社,1998:98.

[7]唐容川.血证论[M].新1版.上海:上海人民出版社,1977:257.

[8]巢元方.诸病源候论[M].黄作阵,点校.沈阳:辽宁科学技术出版社,1997:691.

[9]陈思邈.银海精微[M].北京:人民卫生出版社,2006:207.

[10]李中梓.雷公炮制药性解[M].金芷君,校注.北京:中国中医药出版社,1998.

[11]张介宾.景岳全书[M].新1版.上海:上海科学技术出版社,1959.

[12]中国中医研究院.蒲辅周医疗经验[M].北京:人民卫生出版社,2005:32.

[13]黄元御.玉楸药解[M].北京:中国医药科技出版社,2016.

[14]王怀隐.太平圣惠方[M].郑金生,汪惟刚,董志珍,校点.北京:人民卫生出版社,2016:43.

[15] TRAISK F,TALLSTEDT L,ABRAHAM-NORDLING M,et al. Thyroid-associated ophthalmopathy after treatment for Graves’ hyperthyroidism with antithyroid drugs or iodine-131[J]. J Clin Endocrinol Metab,2009,94(10):3700-3707.

基本信息:

DOI:10.16295/j.cnki.0257-358x.2023.05.017

中图分类号:R259;R276.7;R249

引用信息:

[1]连李荣,叶哲,梁家畅,等.赵恒侠从阴虚夹瘀论治甲状腺相关眼病合并胫前黏液性水肿[J],2023,42(05):514-517.DOI:10.16295/j.cnki.0257-358x.2023.05.017.

基金信息:

广东省基础与应用基础研究基金项目(编号:2019A1515110108);; 陕西中医药大学张学文国医大师中医传承内分泌工作团队项目(编号:SZSM201512043);; 李惠林广东省名老中医药专家传承工作室项目(粤中医办函[2022]52号)

检 索 高级检索